Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2025 View Full Press Release Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Travere Therapeutics to Report Third Quarter 2025 Financial Results